A detailed history of Mario Gabelli (Gamco Investors, Inc. Et Al) transactions in Surmodics Inc stock. As of the latest transaction made, Gamco Investors, Inc. Et Al holds 146,398 shares of SRDX stock, worth $5.58 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
146,398
Previous 160,000 8.5%
Holding current value
$5.58 Million
Previous $6.73 Million 15.6%
% of portfolio
0.06%
Previous 0.08%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$38.47 - $42.24 $523,268 - $574,548
-13,602 Reduced 8.5%
146,398 $5.68 Million
Q2 2024

Aug 13, 2024

BUY
$25.39 - $42.1 $2.24 Million - $3.72 Million
88,400 Added 123.46%
160,000 $6.73 Million
Q1 2024

May 14, 2024

SELL
$27.44 - $35.56 $82,320 - $106,680
-3,000 Reduced 4.02%
71,600 $2.1 Million
Q3 2023

Nov 08, 2023

SELL
$28.28 - $38.36 $65,044 - $88,228
-2,300 Reduced 2.99%
74,600 $2.39 Million
Q2 2023

Aug 10, 2023

BUY
$17.67 - $31.31 $7,068 - $12,524
400 Added 0.52%
76,900 $2.41 Million
Q1 2023

May 12, 2023

BUY
$17.13 - $38.52 $245,781 - $552,684
14,348 Added 23.09%
76,500 $1.74 Million
Q4 2022

Feb 13, 2023

BUY
$29.44 - $37.31 $69,242 - $87,753
2,352 Added 3.93%
62,152 $2.12 Million
Q2 2021

Aug 13, 2021

SELL
$51.29 - $59.15 $51,290 - $59,150
-1,000 Reduced 1.64%
59,800 $3.24 Million
Q1 2021

May 14, 2021

BUY
$42.18 - $56.07 $379,620 - $504,630
9,000 Added 17.37%
60,800 $3.41 Million
Q2 2020

Aug 13, 2020

SELL
$31.07 - $44.74 $136,210 - $196,140
-4,384 Reduced 7.8%
51,800 $2.24 Million
Q1 2020

May 14, 2020

SELL
$22.46 - $42.24 $22,460 - $42,240
-1,000 Reduced 1.75%
56,184 $1.87 Million
Q4 2019

Feb 14, 2020

BUY
$39.01 - $47.51 $224,385 - $273,277
5,752 Added 11.18%
57,184 $2.37 Million
Q1 2019

May 02, 2019

SELL
$41.26 - $58.35 $61,436 - $86,883
-1,489 Reduced 2.81%
51,432 $2.24 Million
Q4 2018

Jan 30, 2019

SELL
$44.93 - $73.38 $74,134 - $121,076
-1,650 Reduced 3.02%
52,921 $2.5 Million
Q3 2018

Nov 02, 2018

SELL
$56.85 - $80.35 $1.28 Million - $1.81 Million
-22,550 Reduced 29.24%
54,571 $4.07 Million
Q2 2018

Aug 10, 2018

SELL
$35.85 - $57.05 $836,272 - $1.33 Million
-23,327 Reduced 23.22%
77,121 $4.26 Million
Q4 2017

Feb 02, 2018

SELL
$28.0 - $33.2 $14,000 - $16,600
-500 Reduced 0.5%
100,448 $2.81 Million
Q3 2017

Nov 01, 2017

BUY
$24.5 - $31.1 $2.47 Million - $3.14 Million
100,948
100,948 $3.13 Million

Others Institutions Holding SRDX

About SURMODICS INC


  • Ticker SRDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,005,000
  • Market Cap $533M
  • Description
  • Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...
More about SRDX
Track Mario Gabelli's Portfolio

Track Mario Gabelli Portfolio

Follow Mario Gabelli (Gamco Investors, Inc. Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gamco Investors, Inc. Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Gamco Investors, Inc. Et Al and Mario Gabelli with notifications on news.